Compounds > chitosan
Page last updated: 2024-08-25

chitosan and imipenem, anhydrous

chitosan has been researched along with imipenem, anhydrous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buranapanitkit, B; Krisanapiboon, A; Oungbho, K1
Azadmehr, A; Fazli, Y; Kohsari, I; Pourmortazavi, SM; Shariatinia, Z1

Other Studies

2 other study(ies) available for chitosan and imipenem, anhydrous

ArticleYear
Biocompatability of hydroxyapatite composite as a local drug delivery system.
    Journal of orthopaedic surgery (Hong Kong), 2006, Volume: 14, Issue:3

    Topics: Amphotericin B; Biocompatible Materials; Calcium Sulfate; Chitosan; Drug Delivery Systems; Durapatite; Fosfomycin; Gentamicins; Humans; Imipenem; Osteoblasts

2006
A novel chitosan-polyethylene oxide nanofibrous mat designed for controlled co-release of hydrocortisone and imipenem/cilastatin drugs.
    International journal of pharmaceutics, 2016, Nov-20, Volume: 513, Issue:1-2

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Chitosan; Cilastatin; Cilastatin, Imipenem Drug Combination; Delayed-Action Preparations; Drug Combinations; Drug Delivery Systems; Drug Liberation; Escherichia coli; Hydrocortisone; Imipenem; Nanofibers; Nanoparticles; Polyethylene Glycols; Staphylococcus aureus; Zinc Oxide

2016